The heterogeneity of human tumour radiation response is well known. Researchers have used the normal distribution to describe interpatient tumour radiosensitivity. However, many natural phenomena show a log-normal distribution. Log-normal distributions are common when mean values are low, variances are large and values cannot be negative. These conditions apply to radiosensitivity. The aim of this work was to evaluate the log-normal distribution to predict clinical tumour control probability (TCP) data and to compare the results with the homogeneous (δ-function with single α-value) and normal distributions. The clinically derived TCP data for four tumour types-melanoma, breast, squamous cell carcinoma and nodes-were used to fit the TCP models. Three forms of interpatient tumour radiosensitivity were considered: the log-normal, normal and δ-function. The free parameters in the models were the radiosensitivity mean, standard deviation and clonogenic cell density. The evaluation metric was the deviance of the maximum likelihood estimation of the fit of the TCP calculated using the predicted parameters to the clinical data. We conclude that (1) the log-normal and normal distributions of interpatient tumour radiosensitivity heterogeneity more closely describe clinical TCP data than a single radiosensitivity value and (2) the log-normal distribution has some theoretical and practical advantages over the normal distribution. Further work is needed to test these models on higher quality clinical outcome datasets.
Introduction
The heterogeneity of the human tumour response to radiation is well known (Dutreix et al 1988 , Bentzen 1992 , Suit et al 1992 , due to histopathologic type, haemoglobin concentration, hypoxic status, cell-proliferation kinetics, immune rejection reactions, etc. For these reasons, and to overcome the unrealistically steep dose-response curve if interpatient heterogeneity is ignored (Brahme 1984) , researchers (Nahum and Tait 1992 , Niemierko and Goitein 1993 , Webb and Nahum 1993 , Webb 1994 ) have accounted for variations in interpatient tumour heterogeneity by assuming that the radiosensitivity (α) values were normally distributed across the population. When compared with clinical tumour control probability (TCP) data collated by Brenner (Brenner 1993) , Webb (Webb 1994) found that the use of the normal distribution demonstrated an improvement in the agreement between predictions over the use of a singular value for α. This result is clinically intuitive based on the variable human response. However, the result is also mathematically intuitive. In the absence of local minima, the two-parameter (mean and standard deviation) normal distribution will fit data at least as well as the singular value fit, given that the singular value is a subset of the normal distribution with the special case of the standard deviation being zero, at which the normal distribution tends towards a singular (δ) function.
Many groups have used the normal distribution to describe interpatient tumour radiosensitivity. The normal distribution is most often assumed to describe the random variation that occurs in the data from many scientific disciplines. However, many natural phenomena show a skewed distribution, such as species' abundance, lengths of latency periods of infectious diseases and the distribution of mineral resources in the Earth's crust (Koch 1966 , Koch 1969 , Limpert et al 2001 . Skewed distributions often closely fit the log-normal distribution and are particularly common when (1) mean values are low, (2) variances are large and (3) values cannot be negative. These three conditions apply to radiosensitivity. Two limitations of using the normal distribution to describe the variation in radiosensitivity can be seen from figure 1. The tail of the distribution crosses α = 0. Negative α values result in an increase in tumour cells with dose; zero α values result in tumours unaffected by radiation. These unwanted effects can be somewhat unsatisfactorily dealt with by truncating the normal distribution at zero (Niemierko and Goitein 1993 , Webb 1994 , Tome and Fowler 2002 . A related limitation of the normal distribution, evidenced from figure 1, is the finite probability of very low radiosensitivity near zero, indicating the existence of a subpopulation of humans who are remarkably radioresistant. In contrast, the log-normal distribution exhibits neither of these properties. A longer tail, however, is seen with the log-normal distribution, which corresponds with including a subpopulation of highly radiosensitive patients (such as those with ataxia telangiectasia).
Interestingly, the log-normal distribution has been demonstrated for exponential cell growth (analogous to cell growth is cell kill by radiation), which is subject to a further symmetric variation (Koch 1966) . For example, if the mean number of cells is 10 6 , one division more or less will be 2 × 10 6 or 5 × 10 5 , respectively. Thus, range will be asymmetric, and the distribution is log-normally distributed.
The aim of this work was to evaluate the application of the log-normal interpatient radiosensitivity distribution to predict clinical TCP data and to compare the results with the homogeneous (single α value) and normal distributions.
Methods
The clinically derived TCP data for four tumour types-(i) malignant melanoma, (ii) breast, (iii) squamous cell carcinoma (SCC) of the upper respiratory and digestive tracts and (iv) nodal control in the upper respiratory and digestive tracts collated by Brenner (Brenner 1993 )-were used to fit the TCP models. The number of tumours for each site were as follows: melanoma: 204 (Overgaard et al 1986) ; breast: 463 (Arriagada et al 1985) ; nodes: 1646 (Bernier and Bataini 1986) ; SCC 749 (Fletcher and Shukovsky 1975, Hall and Cox 1989) . The TCP data was grouped by the dose D and tumour volume V .
For the case of melanoma, where the β component of the linear quadratic model was assumed to be negligible (Webb 1994) , the interpatient tumour radiosensitivity heterogeneity for the population had the probability density function f (α) and the clonogen cell density was ρ, the TCP can be estimated by
The formalism for the other three tumour types (where the β component is non-zero and accounted for in the same way as Webb (Webb 1994) ) was similarly derived.
In equation (1), TCP, D and V are known. The radiosensitivity probability density function, f (α), parameters are determined by maximizing the agreement between the calculated and the clinical data. The variation in delivered dose over the tumour was not directly a free parameter, however. By reviewing equation (1), the variation in α at each dose level, D, implicitly accounts for variations in the tumour dose delivered.
Three forms of interpatient tumour radiosensitivity, f (α), were considered here:
1. The commonly used singular α value (or a delta function δ(α), referred to henceforth as
with mean α N 0 and variance σ N α Table 1 . The optimum values of α 0 and σ α for the δ, normal and log-normal distributions with ρ = 10 7 , together with the corresponding minimum deviance value (cf Webb table 2). 
The metric used to estimate the optimal parameters of ρ, α δ , α
was the minimum of the deviance of the maximum-likelihood estimation. If the calculated TCP is given by p i = TCP(V i , D i ), and the observed TCP is given byp i = TCP(V i , D i ; Obs) for n i patients in each data bin (assumed constant for each dataset), the deviance is
The minimum square difference between the predicted and the clinical data, referred to by Webb (1994) as the 'quadratic' cost function, , was also calculated. The results using the metric for this work matched those of Webb for the normal distribution (results not shown). The optimal parameters were determined using an exhaustive search method by varying ρ from 1 to 10 9 cells cm −3 in decade increments. The α range was 0.005 to 0.6 in 0.005 increments. σ α ranged from 0 to 0.25 in 0.005 increments. The normal and log-normal distributions were sampled 4 × 10 4 times for each (ρ, α, σ α ) triplet. The optimal values of α and σ α were determined for the specific case of ρ = 10 7 cells cm −3 , the cell density used by Nahum and Tait (1992) , based on private communication with G G Steel to obtain best fits for normally distributed α and σ α values for bladder tumours.
To estimate whether the log-normal and normal distributions were significantly different from the delta function distribution, a likelihood ratio test was performed, which is equivalent to
which has a chi-squared distribution with one degree of freedom.
Results
Optimal parameters for ρ = 10 7 cells cm
The optimum values of α 0 and σ α obtained for the δ, normal and log-normal distributionsassuming a uniform cell density ρ = 10 7 , together with the corresponding minimum deviance value-are given in table 1 (cf Webb table 2 ). The minimum deviance values of the log-normal and normal distributions are lower than those for the δ distribution, indicating a significantly better fit to the underlying data. The minimum deviance values for the log-normal and normal distributions were similar. Both the α 0 and σ α values for the log-normal distribution are slightly higher than those of the normal distribution. Due to the precision of the CPU, deviance values for the melanoma data calculated for the δ-function distribution above 10 4 cells cm -3 could not be finitely evaluated.
Optimal parameters as a function of clonogenic cell density
Probability density functions for the δ-function, normal and log-normal distributions are shown in figure 1 . The δ-function assumes that all patients have similar tumour heterogeneity. The normal distribution allows for negative α values, which for radiobiological modelling purposes are typically either set to zero or resampled (performed in this work). The normal curve also includes a subpopulation of extremely radioresistant patients. The log-normal curve has a longer tail than the normal curve, indicating the inclusion of more radiosensitive patients than the normal distribution.
The optimum values of α 0 and σ α for the δ, normal and log-normal distributions with varying ρ-together with the corresponding minimum deviance value for fitting the clinical data-are shown in table 2 (melanoma), table 3 (breast), table 4 (squamous cell carcinoma) and table 5 (nodes). Both the normal and log-normal distributions match the clinical data significantly better than the δ-function distribution. The means and standard deviations of the normal and log-normal distributions are similar for all of the tumour types and clonogenic cell density values investigated, with the log-normal means and the standard deviations being, on average, slightly higher for the log-normal distribution.
The deviance as a function of clonogenic density is plotted in figure 2 for the four tumour types. The plots show that the normal and log-normal distributions match the clinical data better than the δ-function distribution and that the match of the normal and log-normal distributions are similar. An interesting finding is the lack of sensitivity of the clonogenic cell density for the deviance of the log-normal and normal distributions. This indicates that this parameter adds little information from a modelling perspective in the maximum likelihood estimation; however, it does signal an important physical basis. The clonogenic cell density is a significant parameter when estimating the deviance using the δ-function distribution, and low values of clonogenic cell density are calculated to have the lowest deviance.
Overall optimal parameters
Using a chi-squared test with one degree of freedom, the log-normal and normal distributions were significantly better fits to the clinical data, and the additional degree of freedom (variation in interpatient radiosensitivity by either the log-normal or normal distributions) added significant information in the maximum likelihood estimation. The maximum likelihood deviances for the log-normal and normal distributions over all tumour types were similar.
TCP predictions compared with clinical data
The clinical data as a function of tumour diameter and dose-along with the TCPs obtained for the δ-function, normal and log-normal distributions-are shown in figure 3 (melanoma), figure 4 (breast), figure 5 (SCC) and figure 6 (nodes). Observed on these plots are the reduction in curvature offered by the normal and log-normal distributions and an overall reduction in discrepancy with the clinical data, compared with the δ-function distribution. Slight differences are observed between the TCP predictions of the normal and log-normal curves.
Discussion
The use of the log-normal distribution to model interpatient radiosensitivity heterogeneity has been studied. The model has been used to match clinical data, with the results compared with homogeneous (single α value or δ-function distribution) and normally distributed interpatient radiosensitivity heterogeneity models. The log-normal distribution has some advantages over the normal distribution in that it only yields positive values and also excludes a subpopulation of extremely radioresistant patients (figure 1). Both the log-normal and normal distributions match the clinical data significantly better than the δ-function distribution. This improvement is expected, based on the known variable human response to radiation and also from a modelling setting in which two-parameter models will give at least as good a model agreement as single-parameter models, which are a subset of the two-parameter model solution space. The normal and log-normal distributions yielded similar results in terms of the match to the clinical TCP values.
Tomé and Fowler (2002) compared log-normal and truncated normal distributions in terms of a surviving fraction at 2Gy (SF2) for assessing the biological impact of cold spots in dose distributions. They found that using a truncated normal distribution for SF2 will yield slightly higher values of TCP as a function of cold volume for a given cold dose, and cold dose for a given cold volume, except for small cold volumes and cold doses for which the two models are in agreement. However, upon inspection of equation (1), as the log of the surviving fraction is related to the radiosensitivity parameter α, the relevant comparison in this context would be the log-normal SF2 distribution (for normal α distribution) with the log-log normal SF2 distribution (for log-normal α distribution). Similarly, Buffa et al assumed a normal α distribution and subsequently a log-normal SF2 distribution in their cervix cancer study (Buffa et al 2001) .
As with any modelling work, the results are limited by the quality of the clinical tumour control data used to match the three models investigated here, as well as by the assumption inherent in the models themselves, such as uniform dose delivery. With volumetric dose information, the dose axis in figures 3-6 would be an estimate of the overall patients' biologic dose using such reduction methods as effective dose (Brahme 1984) , equivalent uniform dose (Niemierko 1997) or biologically effective uniform dose (Mavroidis et al 2001) . An alternative to dose reduction methods would be to explicitly include the tumour dose distribution as an integral rather than a single value, as shown in equation (1). It is hoped that improved imaging and image-guided delivery will allow the compilation of improved clinical data with which to test the models, potentially demonstrating statistical significance.
Conclusion
The log-normal and normal distributions of interpatient tumour radiosensitivity heterogeneity more closely describe clinical TCP data than a single radiosensitivity value. The log-normal and normal distributions describe the clinical data similarly, both in terms of shape and overall deviation from the measured data points. The log-normal distribution has some theoretical and practical advantages over the normal distribution and, thus, is worthy of further investigation. Further work is needed to test these models on higher quality clinical outcome datasets.
